Last reviewed · How we verify

NCT04514172

Testing the Effectiveness and Safety of a Passive Industrial Exoskeleton for Back Support

Completed NA Last updated 9 October 2020
What this trial tests

NA trial testing Passive industrial exoskeleton for back support in Prevention of Diseases of the Musculoskeletal System in 12 participants. Completed in 5 September 2020.

Timeline
22 July 2020
Primary endpoint
5 September 2020
5 September 2020

Quick facts

Lead sponsorFederal State Budgetary Scientific Institution "Izmerov Research Institute of Occupational Health"
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeprevention
Enrollment12
Start date22 July 2020
Primary completion5 September 2020
Estimated completion5 September 2020
Sites1 location across Russia

Drugs / interventions tested

Conditions studied

Sponsor

Federal State Budgetary Scientific Institution "Izmerov Research Institute of Occupational Health"

Who can join

Adults 18 to 45, male only, with Prevention of Diseases of the Musculoskeletal System. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research will provide data on evaluation of the effectiveness and safety of using a passive exoskeleton designed to reduce the negative impact of static and dynamic loads associated with body tilts, lifting and holding weights on the musculoskeletal system of workers. To evaluate a passive industrial exoskeleton for back support, a protocol was developed in which individual production operations will be modeled.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Federal State Budgetary Scientific Institution "Izmerov Research Institute of Occupational Health" trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04514172.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing